A non-disclosure agreement is one of the foundational legal instruments in business. It creates a contractual obligation to keep shared information confidential and provides legal recourse if that obligation is breached. NDAs are used in virtually every industry — from software development to manufacturing to healthcare — whenever sensitive business information crosses organizational boundaries.
One-way vs. mutual NDAs. A unilateral NDA flows in one direction: the disclosing party shares information, and the receiving party commits to protecting it. This is typical in vendor relationships, hiring processes, and investor pitches. A mutual NDA obligates both parties — used when both sides will be exchanging sensitive information, as in partnership discussions, joint ventures, or M&A diligence.
Key provisions explained. The definition of Confidential Information is the most important clause — it should be broad enough to cover all sensitive disclosures but include standard carve-outs for public information, prior knowledge, and independent development. The permitted disclosure clause allows sharing with employees who need to know. The remedies clause (injunctive relief) is critical because monetary damages are often inadequate for trade secret breaches.
Trade secrets vs. confidential information. Trade secret protection under the Defend Trade Secrets Act (DTSA) provides federal remedies independent of a contract, but trade secrets must meet specific standards: they must derive economic value from secrecy and must be subject to reasonable protective measures. An NDA is one element of demonstrating that you take reasonable measures to protect your trade secrets.
Non-solicitation clauses. Many NDAs include a non-solicitation clause preventing parties from poaching each other's employees who were involved in the disclosed work. Non-solicitation clauses are generally more enforceable than non-compete clauses, which face increasing legal scrutiny. California largely prohibits both; check state law before including either.
When to use an attorney. This generator produces a solid starting point for standard business NDAs. For M&A transactions, investor agreements, pharmaceutical or biotech disclosures, or any situation where the disclosed information is worth millions of dollars, engage an attorney. The cost of proper legal review is insignificant compared to the value at risk.